Literature DB >> 26589753

The effect of fibroblast growth factor on distinct differentiation potential of cord blood-derived unrestricted somatic stem cells and Wharton's jelly-derived mesenchymal stem/stromal cells.

Seungok Lee1, Byung-Joon Park2, Ji Yeon Kim3, DongWook Jekarl1, Hyun Yoo Choi3, Seong Yeoun Lee3, Myungshin Kim4, Yonggoo Kim5, Moon-Seo Park6.   

Abstract

BACKGROUND AIMS: Perinatal tissues are considered an attractive source of mesenchymal stem/stromal cells (MSCs) and have unique characteristics depending on their origin. In this study, we compared the basic characteristics of unrestricted somatic stem cells isolated from cord blood (CB-USSCs) and MSCs isolated from Wharton's jelly of umbilical cords (WJ-MSCs). We also evaluated the effect of basic fibroblast growth factor (bFGF) supplementation on the growth and differentiation of these cells.
METHODS: CB-USSCs and WJ-MSCs were isolated from the same individual (n = 6), and their morphology, cell surface antigens, proliferation, expression of stemness markers and adipogenic, osteogenic and chondrogenic differentiation potentials were evaluated. Their morphology, proliferation and differentiation potentials were then also compared in the presence of bFGF supplementation (10 ng/mL).
RESULTS: Overall, CB-USSCs expressed DLK-1 and negative for all the HOX gene markers. The expression of cell surface antigen CD90, growth capacity and adipogenic differential potential of CB-USSCs were lower than those of WJ-MSCs. WJ-MSCs showed higher growth capacity, but the expression of CD73 and CD105 and their osteogenic differentiation potential were lower than those of CB-USSCs. The spindle morphology of both CB-USSCs and WJ-MSCs and the growth and adipogenic differentiation of CB-USSCs were improved by bFGF supplementation. However, the bFGF supplement did not have any positive effect on the tri-lineage differentiation potentials of WJ-MSCs.
CONCLUSIONS: CB-USSCs and WJ-MSCs each had distinct characteristics including different growth capacity, distinguishable cell surface markers and distinct adipogenic and osteogenic potentials. bFGF supplementation improved the growth capacity and adipogenic differentiation of CB-USSCs.
Copyright © 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Wharton's jelly; basic fibroblast growth factor; mesenchymal stem/stromal cells; umbilical cord blood; unrestricted somatic stem cells

Mesh:

Substances:

Year:  2015        PMID: 26589753     DOI: 10.1016/j.jcyt.2015.09.007

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  5 in total

Review 1.  The Role of Pref-1 during Adipogenic Differentiation: An Overview of Suggested Mechanisms.

Authors:  Carina da Silva; Chrisna Durandt; Karlien Kallmeyer; Melvin A Ambele; Michael S Pepper
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

2.  Transcriptome analysis of basic fibroblast growth factor treated stem cells isolated from human exfoliated deciduous teeth.

Authors:  Nunthawan Nowwarote; Jeeranan Manokawinchoke; Kiattipan Kanjana; Benjamin P J Fournier; Waleerat Sukarawan; Thanaphum Osathanon
Journal:  Heliyon       Date:  2020-06-25

3.  Stromal cell-derived factor loaded co-electrospun hydrophilic/hydrophobic bicomponent membranes for wound protection and healing.

Authors:  Robin Augustine; Syed Raza Ur Rehman; Joshy K S; Anwarul Hasan
Journal:  RSC Adv       Date:  2020-12-24       Impact factor: 3.361

4.  Wharton's Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy: A Pilot Study.

Authors:  Serdar Kabataş; Erdinç Civelek; Çiğdem İnci; Ebru Yılmaz Yalçınkaya; Gülşen Günel; Gülay Kır; Esra Albayrak; Erek Öztürk; Gökhan Adaş; Erdal Karaöz
Journal:  Cell Transplant       Date:  2018-09-11       Impact factor: 4.064

5.  A New Approach to Cerebral Palsy Treatment: Discussion of the Effective Components of Umbilical Cord Blood and its Mechanisms of Action.

Authors:  Yang Jiao; Xiao-Yan Li; Jing Liu
Journal:  Cell Transplant       Date:  2018-11-01       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.